Baltzer WI et al. |
Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. |
2006 |
Am. J. Vet. Res. |
pmid:16426215
|
Hoh CM et al. |
Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. |
2011 |
Am. J. Vet. Res. |
pmid:21801060
|
Lupinetti MD et al. |
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. |
1989 |
Am. Rev. Respir. Dis. |
pmid:2508524
|
Kumlin M et al. |
Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1320824
|
Schweer H et al. |
Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. |
1987 |
Anal. Biochem. |
pmid:3674365
|
Cavalca V et al. |
Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry. |
2010 |
Anal. Biochem. |
pmid:19825360
|
Lawson JA et al. |
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. |
1986 |
Anal. Biochem. |
pmid:3087234
|
Hayashi Y et al. |
Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. |
1990 |
Anal. Biochem. |
pmid:2372112
|
Riutta A et al. |
Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. |
1992 |
Anal. Biochem. |
pmid:1519756
|
Di Minno MN et al. |
Increased platelet reactivity in Klinefelter men: something new to consider. |
2015 |
Andrology |
pmid:26216452
|
Carroll RC et al. |
A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. |
2013 |
Anesth. Analg. |
pmid:23302970
|
Foulon I et al. |
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. |
1993 |
Arterioscler. Thromb. |
pmid:8443146
|
Bröijersén A et al. |
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9081681
|
Davi G et al. |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. |
1997 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:9409316
|
Davì G et al. |
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15472127
|
Stein CM et al. |
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. |
1996 |
Arthritis Rheum. |
pmid:8670323
|
Cracowski JL et al. |
Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. |
2001 |
Arthritis Rheum. |
pmid:11352247
|
Ferro D et al. |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. |
1999 |
Arthritis Rheum. |
pmid:10616019
|
Jörres A et al. |
Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. |
1994 |
Artif Organs |
pmid:7527629
|
Takayama K et al. |
Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. |
1991 Jul-Sep |
ASAIO Trans |
pmid:1836334
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Calapai G et al. |
Cardiovascular biomarkers in groups of established smokers after a decade of smoking. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19175368
|
Liu TF et al. |
[Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. |
2015 |
Beijing Da Xue Xue Bao |
pmid:26679651
|
Varma D et al. |
Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". |
2011 |
Bioanalysis |
pmid:21510759
|
Ciabattoni G et al. |
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. |
1989 |
Biochim. Biophys. Acta |
pmid:2752040
|
Patrignani P et al. |
Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. |
1989 |
Biochim. Biophys. Acta |
pmid:2752041
|
Wu P et al. |
Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay. |
1990 |
Biochim. Biophys. Acta |
pmid:2223826
|
Lorenz RL et al. |
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. |
1989 |
Biochim. Biophys. Acta |
pmid:2597697
|
Ciabattoni G et al. |
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. |
1987 |
Biochim. Biophys. Acta |
pmid:3567215
|
Lüdicke F et al. |
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. |
2015 |
Biomarkers |
pmid:26616146
|
Milani M et al. |
Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia. |
1996 |
Biomed. Pharmacother. |
pmid:8952866
|
Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|
Wang ZY et al. |
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. |
2001 |
Blood Coagul. Fibrinolysis |
pmid:11685040
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Bridges AB et al. |
Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. |
1991 |
Blood Coagul. Fibrinolysis |
pmid:1932530
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Ferretti A and Flanagan VP |
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. |
1995 |
Chem. Phys. Lipids |
pmid:7586090
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Kurokawa K et al. |
Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. |
2001 |
Chest |
pmid:11742908
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|